Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 373

1.

Economic evaluation of varicella vaccination in Spain: results from a dynamic model.

Lenne X, Diez Domingo J, Gil A, Ridao M, Lluch JA, Dervaux B.

Vaccine. 2006 Nov 17;24(47-48):6980-9. Epub 2006 May 4.

PMID:
16860909
2.

Varicella vaccination in Italy : an economic evaluation of different scenarios.

Coudeville L, Brunot A, Giaquinto C, Lucioni C, Dervaux B.

Pharmacoeconomics. 2004;22(13):839-55.

PMID:
15329030
3.

Can varicella be eliminated by vaccination? Potential clinical and economic effects of universal childhood varicella immunisation in Germany.

Wutzler P, Neiss A, Banz K, Goertz A, Bisanz H.

Med Microbiol Immunol. 2002 Oct;191(2):89-96. Epub 2002 Aug 29.

PMID:
12410347
4.

Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States.

Ortega-Sanchez IR, Meltzer MI, Shepard C, Zell E, Messonnier ML, Bilukha O, Zhang X, Stephens DS, Messonnier NE; Active Bacterial Core Surveillance Team.

Clin Infect Dis. 2008 Jan 1;46(1):1-13. doi: 10.1086/524041.

6.

The cost-effectiveness of routine childhood varicella vaccination in Germany.

Banz K, Wagenpfeil S, Neiss A, Goertz A, Staginnus U, Vollmar J, Wutzler P.

Vaccine. 2003 Mar 7;21(11-12):1256-67.

PMID:
12559807
7.

Cost-effectiveness analysis of universal childhood vaccination against varicella in Brazil.

Valentim J, Sartori AM, de Soárez PC, Amaku M, Azevedo RS, Novaes HM.

Vaccine. 2008 Nov 18;26(49):6281-91. doi: 10.1016/j.vaccine.2008.07.021. Epub 2008 Jul 30.

PMID:
18674582
8.

Varicella vaccination in England and Wales: cost-utility analysis.

Brisson M, Edmunds WJ.

Arch Dis Child. 2003 Oct;88(10):862-9.

9.

An economic analysis of the universal varicella vaccination program in the United States.

Zhou F, Ortega-Sanchez IR, Guris D, Shefer A, Lieu T, Seward JF.

J Infect Dis. 2008 Mar 1;197 Suppl 2:S156-64. doi: 10.1086/522135.

10.

The economic value of childhood varicella vaccination in France and Germany.

Coudeville L, Brunot A, Szucs TD, Dervaux B.

Value Health. 2005 May-Jun;8(3):209-22.

11.

The cost-effectiveness of varicella vaccination in Canada.

Brisson M, Edmunds WJ.

Vaccine. 2002 Jan 15;20(7-8):1113-25.

PMID:
11803072
12.

An economic evaluation of varicella vaccination in Italian adolescents.

Thiry N, Beutels P, Tancredi F, Romanò L, Zanetti A, Bonanni P, Gabutti G, Van Damme P.

Vaccine. 2004 Sep 9;22(27-28):3546-62.

PMID:
15315834
13.

Varicella in French adolescents and adults: individual risk assessment and cost-effectiveness of routine vaccination.

Hanslik T, Boëlle PY, Schwarzinger M, Carrat F, Freedberg KA, Valleron AJ, Flahault A.

Vaccine. 2003 Sep 8;21(25-26):3614-22.

PMID:
12922090
14.

Instituting a routine varicella vaccination program in Canada: an economic evaluation.

Getsios D, Caro JJ, Caro G, De Wals P, Law BJ, Robert Y, Lance JM.

Pediatr Infect Dis J. 2002 Jun;21(6):542-7.

PMID:
12182379
15.

Varicella epidemiology and cost-effectiveness analysis of universal varicella vaccination program in Taiwan.

Tseng HF, Tan HF, Chang CK.

Southeast Asian J Trop Med Public Health. 2005 Nov;36(6):1450-8.

PMID:
16610647
16.

[Modelling the impact of vaccination on the epidemiology of varicella zoster virus].

Bonmarin I, Santa-Olalla P, Lévy-Bruhl D.

Rev Epidemiol Sante Publique. 2008 Oct;56(5):323-31. doi: 10.1016/j.respe.2008.07.087. Epub 2008 Oct 31. French.

PMID:
18951741
17.

Economic evaluation of the 7-vaccine routine childhood immunization schedule in the United States, 2001.

Zhou F, Santoli J, Messonnier ML, Yusuf HR, Shefer A, Chu SY, Rodewald L, Harpaz R.

Arch Pediatr Adolesc Med. 2005 Dec;159(12):1136-44.

PMID:
16330737
18.

Economic burden of varicella in Singapore--a cost benefit estimate of implementation of a routine varicella vaccination.

Jean-Jasmin LM, Lynette SP, Stefan M, Kai CS, Chew FT, Wah LB.

Southeast Asian J Trop Med Public Health. 2004 Sep;35(3):693-6.

PMID:
15689089
19.
20.

Universal vaccination of children against hepatitis A in Chile: a cost-effectiveness study.

Quezada A, Baron-Papillon F, Coudeville L, Maggi L.

Rev Panam Salud Publica. 2008 May;23(5):303-12.

PMID:
18510790
Items per page

Supplemental Content

Write to the Help Desk